miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
Nature Medicine2010Vol. 16(10), pp. 1134–1140
Citations Over TimeTop 10% of 2010 papers
Alexander Swarbrick, Susan L. Woods, Alexander Shaw, Asha Balakrishnan, Yuwei Phua, Akira Nguyen, Yvan H. Chanthery, Lionel Lim, Lesley J. Ashton, Robert L. Judson, Noelle E. Huskey, Robert Blelloch, Michelle Haber, Murray D. Norris, Péter Lengyel, Christopher S. Hackett, Thomas Preiß, Albert Chetcuti, Christopher S. Sullivan, Eric G. Marcusson, William A. Weiss, Noëlle D. L’Étoile, Andrei Goga
Related Papers
- → Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas(2008)270 cited
- → Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma.(1984)404 cited
- → Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma(2018)36 cited
- → The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma(2019)29 cited
- → Coamplification of DDX1 Correlates With an Improved Survival Probability in Children With MYCN-Amplified Human Neuroblastoma(2004)45 cited